Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
Stanislas Pol
◽
Anaïs Vallet-Pichard
◽
Marion Corouge
2017 ◽
Vol 48
(3)
◽
pp. E146-E154
◽
Goki Suda
◽
Jun Ito
◽
Atsushi Nagasaka
◽
Yoshiya Yamamoto
◽
Ken Furuya
◽
...
2020 ◽
Vol 15
(4)
◽
pp. 139-145
Shunji Watanabe
◽
Naoki Morimoto
◽
Kouichi Miura
◽
Toshimitsu Murohisa
◽
Toshiyuki Tahara
◽
...
2015 ◽
Vol 87
(7)
◽
pp. 1199-1206
◽
Naoki Harada
◽
Naoki Hiramatsu
◽
Tsugiko Oze
◽
Tomohide Tatsumi
◽
Norio Hayashi
◽
...
2019 ◽
Vol 18
(5)
◽
pp. 708-714
◽
Victor de Ledinghen
◽
Bertrand Hanslik
◽
Joseph Moussalli
◽
Si Nafa Si Ahmed
◽
Denis Ouzan
◽
...
2008 ◽
Vol 14
(40)
◽
pp. 6195
◽
Patrice Cacoub
◽
Denis Ouzan
◽
Pascal Melin
◽
Jean-Philippe Lang
◽
Michel Rotily
◽
...
2016 ◽
Vol 64
(2)
◽
pp. S769-S770
◽
G. Esmat
◽
H.G. Eldeen
◽
M. El Kassas
◽
M. El Raziky
◽
T. Elbaz
◽
...
2015 ◽
Vol 163
(11)
◽
pp. 809
◽
Stephen Pianko
◽
Steven L. Flamm
◽
Mitchell L. Shiffman
◽
Sonal Kumar
◽
Simone I. Strasser
◽
...
2006 ◽
Vol 26
(7)
◽
pp. 1127-1129
◽
Francesca Bellisai
◽
Chiara Giannitti
◽
Alessandro Donvito
◽
Mauro Galeazzi
1999 ◽
Vol 3
(4)
◽
pp. 329-333
◽
Hideyasu Kiyomoto
◽
Hirofumi Hitomi
◽
Youko Hosotani
◽
Mayuko Hashimoto
◽
Kouichi Uchida
◽
...
Milan Sencanski
◽
Sanja Glisic